[Stent placement or acute resection in colonic obstruction?]

Area of Science:

• Gastroenterology
• Surgical Oncology
• Interventional Endoscopy

Background:

• Obstructing left-sided colonic carcinoma presents a complex treatment challenge.
• Treatment decisions are stratified based on patient surgical risk.
• Current guidelines recommend different approaches for high-risk versus low-risk individuals.

Purpose of the Study:

• To delineate optimal treatment strategies for obstructing left-sided colonic carcinoma.
• To define the role of colonic stent placement in managing malignant bowel obstruction.
• To identify patient subgroups who benefit most from palliative stenting versus acute resection.

Main Methods:

• Review of treatment protocols for left-sided colonic carcinoma.
• Analysis of outcomes for patients undergoing stent placement versus acute resection.
• Evaluation of risks associated with colonic stenting, including perforation and angiogenesis inhibitor interactions.

Main Results:

• Patients with increased surgical risk (age > 70 or ASA class ≥ 3) are candidates for stent placement as a bridge to surgery or decompressing colostomy.
• Acute resection is the primary treatment for patients without increased surgical risk due to oncological concerns.
• Palliative stent placement is indicated for malignant obstruction, with caution advised for patients on angiogenesis inhibitors (e.g., bevacizumab) due to increased perforation risk.
• Colonic stent procedures require demonstrated expertise (≥20 cases).

Conclusions:

• Treatment selection for obstructing left-sided colonic carcinoma must consider individual patient surgical risk.
• Colonic stenting offers a viable bridge to surgery or palliative option for select patients.
• Careful patient selection and consideration of concurrent therapies are crucial to minimize complications associated with colonic stent placement.